Dr David Bailey

Dr David Bailey

CEO

IOTA Pharmaceuticals

Speaker

Talks at BSP Trypanosomiasis and Leishmaniasis Seminar 2016

Sun4 Sep03:30pm(25 mins)	Keynote: SME perspective: Building international scientific networks to tackle neglected parasitic diseases: the EU NPD Project as a Case Study
	Session: Kinoplast Breeders Room: Lecture theatre

Profile of Dr David Bailey

Dr David Bailey is CEO of IOTA Pharmaceuticals, Cambridge, UK. Previously David worked in Tumor and Cell Biology at SmithKline in Philadelphia, and headed up Molecular Sciences and Ant-Infectives R&D at Pfizer in the UK, before moving to Incyte Pharmaceuticals in California. His interests centre on applying genomics, SBDD and chemical biology in pharmaceutical drug discovery. IOTA works primarily in the Anti-infectives and Oncology therapeutic areas.

Email

Please login to send a Private Message

Hosted By

British Society for Parasitology (BSP)

We are science based charitable society.

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'Klebo'

Privacy Notice